A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial Evaluating the Efficacy of Burosumab, an Anti-FGF23 Antibody, in Adults With X-Linked Hypophosphatemia: Week 24 Primary Analysis

Impaired quality of life in adults with X-linked hypophosphatemia and skeletal symptoms

(2016) Hélène Che et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Hypophosphatemia promotes lower rates of muscle ATP synthesis

(2016) Dominik H. Pesta et al.   FASEB JOURNAL

Prolonged Correction of Serum Phosphorus in Adults With X-Linked Hypophosphatemia Using Monthly Doses of KRN23

(2015) Erik A. Imel et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Randomized trial of the anti-FGF23 antibody KRN23 in X-linked hypophosphatemia

(2014) Thomas O. Carpenter et al.   JOURNAL OF CLINICAL INVESTIGATION

Therapeutic management of hypophosphatemic rickets from infancy to adulthood

(2014) Agnès Linglart et al.   Endocrine Connections

Abnormalities in Muscle Density and Muscle Function in Hypophosphatemic Rickets

(2012) Louis-Nicolas Veilleux et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

FGF23 production by osteocytes

(2012) Lynda F. Bonewald et al.   PEDIATRIC NEPHROLOGY

Rickets: Part I

(2012) Richard M. Shore et al.   PEDIATRIC RADIOLOGY

A clinician's guide to X-linked hypophosphatemia

(2011) Thomas O Carpenter et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Circulating Levels of Soluble Klotho and FGF23 in X-Linked Hypophosphatemia: Circadian Variance, Effects of Treatment, and Relationship to Parathyroid Status

(2010) Thomas O. Carpenter et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Treatment of X-Linked Hypophosphatemia with Calcitriol and Phosphate Increases Circulating Fibroblast Growth Factor 23 Concentrations

(2010) Erik A. Imel et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM